Institutional Ownership
Voyager Therapeutics Inc
CUSIP 92915B106COMVYGRQ1 2026
13D / 13G Filings
38
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
130
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
38 filings · latest Feb 18, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 18, 2026 | Armistice Capital, LLC | 13G/A | 7.2% | 4.00M | SEC |
| 2 | Feb 17, 2026 | Ecor1 Capital, LLC | 13G/A | 6.8% | — | SEC |
| 3 | Jan 26, 2026 | Integrated Core Strategies (Us) LLC | 13G | 11.0% | 3.41M | SEC |
| 4 | Nov 14, 2025 | Armistice Capital, LLC | 13G/A | 7.6% | 4.20M | SEC |
| 5 | Nov 14, 2025 | Ecor1 Capital, LLC | 13G/A | 6.8% | — | SEC |
| 6 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 9.8% | 5.44M | SEC |
| 7 | Apr 24, 2025 | Blackrock, Inc. | 13G/A | 6.4% | 3.53M | SEC |
| 8 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 9.9% | 5.40M | SEC |
| 9 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 9.5% | 5.20M | SEC |
| 10 | Nov 14, 2024 | Ecor1 Capital, LLC | 13G/A | 10.0% | 5.62M | SEC |
28 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Voyager Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 5.57M | $21.49M |
| 2 | Armistice Capital, LLC | 3.50M | $13.51M |
| 3 | Millennium Management LLC | 3.43M | $13.23M |
| 4 | Vestal Point Capital, LP | 3.00M | $11.59M |
| 5 | Opaleye Management Inc. | 1.15M | $4.44M |
| 6 | Erste Asset Management Gmbh | 1.10M | $4.24M |
| 7 | Geode Capital Management, LLC | 1.05M | $4.05M |
| 8 | State Street Corp | 948.2K | $3.66M |
| 9 | Dimensional Fund Advisors LP | 875.6K | $3.38M |
| 10 | Morgan Stanley | 681.7K | $2.63M |